Chapter 23: Management of Patients with Coronary Vascular Disorders
Welcome to Last Minute Lecture.
This free chapter overview is designed to help students review and understand key concepts.
These summaries supplement not replaced the original textbook and may not be redistributed or resold.
For complete coverage, always consult the official text.
Welcome back to The Deep Dive.
Our mission today is to take a massive dense clinical resource Chapter 23 of Brunner and Sutterth's and really distill it.
We're talking about coronary vascular disorder.
Yeah, this is the blueprint for cardiovascular care.
It really is.
So we're going to give you a structured shortcut through all of it.
The pathophysiology, the assessments, the drugs, everything.
And this is foundational stuff.
I mean, cardiovascular disease is the leading cause of death in the United States.
Across all demographics.
Right.
So to be effective, you have to understand the why and the how.
We're going to follow the textbook exactly, from the microscopic level all the way to long term rehab.
Okay, so let's lock in some core vocabulary first.
These terms will be our guideposts.
The main one is coronary artery disease or CAD.
It's the most common type of heart disease in adults.
And it's caused by atherosclerosis.
Which is that abnormal buildup of lipids and fibrous tissue inside the artery wall.
Exactly.
And when those fatty streaks get bigger, they form a plaque or an atheroma.
And that plaque narrows the arteries.
So when the heart needs more oxygen than it can get.
That's when you get angina pictoris.
Chest pain.
It's the classic sign of myocardial ischemia.
Which can then escalate very quickly into what we call acute coronary syndrome or ACS.
Yes, and ACS is an emergency.
It's an umbrella term that covers everything from unstable angina right up to an acute myocardial infarction and MI.
A heart attack.
The actual death of heart tissue from lack of oxygen.
Right.
And then finally, we'll talk about how we fix it.
PCI or percutaneous coronary intervention.
That's the non -surgical approach like balloons and stents.
Exactly.
And the more invasive option is CABG or coronary artery bypass grafting.
Open heart surgery.
Okay.
A lot to cover.
Let's start at the very beginning with the disease itself.
Coronary artery disease.
The source material makes it really clear.
This all starts with an injury.
An injury and an inflammatory trigger.
It's not just about diet.
Not at all.
It begins with damage to that delicate inner lining of the artery.
The vascular endothelium.
And a healthy endothelium is protective, right?
It is.
It produces things that prevent clots and keep the vessel dilated.
But once it's injured, it stops doing that.
It becomes dysfunctional.
So the body sees an injury and sends in the cleanup crew inflammation.
But here, the inflammatory cells actually become the problem.
Macrophages get drawn to the site and they start eating up lipids, especially LDL cholesterol.
The bad cholesterol.
Right.
And once they're full of fat, we call them foam cells, they deposit these lipids into the artery wall.
And that's how you get those early fatty streaks.
And the textbook mentions that oxidized LDL is actually toxic.
It is.
It creates this vicious cycle of more damage, more inflammation.
So that leads to the mature plaque, the atheroma.
Yes.
And then smooth muscle cells migrate to the area.
They start to multiply and form a fibrous cap over that lipid core.
Okay.
And this is where the textbook makes a really crucial distinction.
The difference between stable and vulnerable plaque.
This is maybe the most important concept because it determines the patient's entire prognosis.
So what's the difference?
If they both narrow the artery, why is one so much more dangerous?
A stable plaque has a really thick fibrous cap.
It's tough.
The lipid pool inside is protected.
So yeah, it causes narrowing and symptoms like angina when you exercise.
Okay.
But the vulnerable plaque,
that's the ticking time bomb.
It has a very thin, fragile cap over a big mushy lipid core.
And if that thin cap ruptures?
The blood comes into contact with that highly thrombogenic core and you get a massive instant blood clot, a thrombus.
And that causes a complete blockage.
Which is the acute MI.
That's the MI.
So it's not just the size of the blockage, it's the integrity of that cap.
And why are the
The textbook points out that it happens most where vessels branch.
The blood flow there is turbulent, not smooth.
Ah, so that mechanical stress contributes to the initial injury.
Precisely.
It starts the whole process.
So if that blockage lasts long enough, we go from reversible ischemia to irreversible damage.
To cell death, myocardial necrosis.
The heart tissue actually dies.
And it gets replaced by scar tissue.
In flexible, non -contractile scar tissue.
So the patient might survive the MI, but that scar impairs the heart's ability to pump.
And that can lead to chronic low cardiac output and eventually heart failure.
Let's talk about how this actually presents.
The book says chest pain is the most common sign, but we know it's not always that simple.
No.
And relying only on chest pain can be a fatal mistake.
You have to assess broadly.
So beyond that classic heavy squeezing,
pain,
what else should we look for?
It can be referred pain.
So patients might just report epigastric distress like heartburn or pain that radiates only to their jaw or their back or their left arm.
And there are specific groups where you have to be extra vigilant for atypical symptoms.
Absolutely.
Think about older adults or patients with long -standing diabetes.
They might not feel typical chest pain at all because of neuropathy or just age -related changes in pain transmission.
So what would they report instead?
It could be really subtle, unexplained weakness, profound fatigue, or just shortness of breath when they exert themselves.
The source also puts a huge emphasis on women.
Yes, this is a major point of concern.
Women often present with things like indigestion, nausea, chronic fatigue, palpitations, or even just numbness.
And because those symptoms can mimic other things like anxiety or GI issues, they often delay seeking care.
And that delay, unfortunately, is linked to higher mortality rates after an event.
So nurses need to be teaching women and their families to recognize these signs?
Absolutely.
And then you have the scariest presentation of all, silent ischemia.
Where there's objective evidence of ischemia like on an ECG, but the patient feels nothing.
Nothing at all.
No warning.
The Framingham study, which the book cites, found that almost 15 % of people who have a major coronary event were completely asymptomatic beforehand.
Wow.
That really underscores the need for screening based on risk, not just symptoms.
Exactly.
Okay, let's shift to those risks.
Chart 23 -1 in the book breaks them down into non -modifiable and modifiable.
The non -modifiable ones are what they sound like.
You can't change them.
They tell us who needs closer screening.
So that's things like family history?
Yes, especially early onset.
So CAD before age 55 and a male relative or 65 and a female relative,
also increasing age, being male and race, there's a higher incidence in African Americans.
And then there are the modifiable factors.
These are our targets for intervention.
These are where we can make a huge difference.
We're talking hyperlipidemia, tobacco use, hypertension,
diabetes, obesity, and physical inactivity.
The textbook then highlights a really dangerous cluster of these called metabolic syndrome.
It's a huge warning sign.
It's not just a list of problems.
It's this
synergistic high -risk state driven by insulin resistance.
And to be diagnosed, you need to have three out of five specific risk factors.
That's right.
The first is a large waist circumference, which indicates a lot of visceral fat.
That's over 35 .4 inches for men or 31 .4 for women.
Why is that visceral fat so specifically dangerous?
Because that abdominal fat is metabolically active.
It's not just sitting there.
It secretes hormones and inflammatory mediators that directly cause insulin resistance and dyslipidemia.
It's actively making the internal environment more prone to plaque.
It's the fat itself creating the problem.
Exactly.
So number two is elevated triglycerides at or above 175.
Number three is reduced HDL, the good cholesterol, less than 40 for men, less than 50 for women.
And the last two.
Fourth is hypertension.
So an average BP of 130 over 80 or higher.
And fifth is elevated fasting glucose, 100 or higher.
Okay.
So if we know these are the risks, the goal is prevention.
Let's start with controlling cholesterol.
First, you have to understand the transport system.
Fats travel in these protein shells called lipoproteins.
The LDLs, LDLs, HDLs.
Right.
And LDL is the main target because it carries cholesterol to the tissues.
HDL is protective because it carries it away.
What are the target values we're aiming for?
For LDL, the bad guy, you want it under 100.
And for very high -risk patients like someone who already has CAD, you want it under 70.
Under 200.
HDL, the good guy, should be over 40 for men, over 50 for women.
And triglycerides under 150.
To get there, the first step is lifestyle.
What are the key dietary recommendations?
The AHA guidelines or the Mediterranean diet.
So lots of plant foods, fish, whole grains, very little red meat, saturated fats or sweets.
The key nursing role here is to make sure the week of moderate aerobic activity or 75 minutes of vigorous activity, plus some muscle strengthening.
But the safety instructions are key.
Absolutely.
You tell them to stop immediately if they feel chest pain, dizziness, or can't carry on a conversation while they're exercising.
When lifestyle changes aren't enough, we move to medications.
Let's walk through table 23 -1, starting with the big one, statins.
Right.
The HMG -CoA reductase inhibitors, drugs like atorvastatin, simvastatin.
They're the cornerstone.
And they work by blocking an enzyme involved in cholesterol synthesis.
Exactly.
So they dramatically lower LDL, but they also increase HDL and have anti -inflammatory effects, which is a huge bonus.
What are the absolute priority nursing considerations for statins?
Well, myalgia muscle pain is common, but you have to watch for the rare but serious complications.
Myopathy and rhabdomyolysis, which is a breakdown of muscle that can damage the kidneys.
And you monitor liver function.
Yes, LFTs are a must.
And one small but important detail.
They're usually given in the evening, because that's when the body's cholesterol synthesis peaks.
Okay.
Next up,
the fibric acids, or fibrates.
Like phenofibrate.
These mostly target triglycerides, lowering them significantly, and they also raise HDL.
What's the main caution with these?
The big warning is when they're used with statins.
The risk of serious side effects, like rhabdo and liver toxicity, goes way up.
It requires really intense monitoring.
Then there are the bile acids, the questions.
Like colesteramine.
These are more of an adjunct therapy.
They work in the gut, binding the bile acids, so the body has to use up cholesterol to make more.
And the side effects are mostly GI.
Mostly GI distress, yeah.
Bloating, constipation.
And because they bind things up, you have to be careful with timing them around other medications.
And finally, the newest class, the PCSK9 inhibitors.
These are powerful.
Drugs like
they're usually for high -risk patients who can't get to their goal with statins.
They cause a massive drop in LDL.
How are they administered?
That's the unique thing.
It's a subcutaneous injection, usually once or twice a month,
and they are very expensive.
Let's move to the other modifiable risks, starting with tobacco.
The book details three ways it damages the cardiovascular system.
And they happen almost instantly.
First, the nicotine rush releases catecholamines, adrenaline.
So that spikes your heart rate and BP and constricts your arteries.
Immediately.
Second, smoking increases the oxidation of LDL, which we already said is toxic to the endothelium.
It directly accelerates plaque formation.
And the third mechanism is about oxygen supply itself.
It's the carbon monoxide.
When you inhale smoke, carbon monoxide binds to your hemoglobin way more strongly than oxygen can.
So it literally suffocates the heart muscle.
It dramatically decreases the oxygen -carrying capacity of your blood.
The good news, though, is that the risk drops significantly within the first year of quitting.
Okay, what about managing hypertension?
The definition now is a BP consistently over 30 -30 -80.
Think of chronic high blood pressure as constantly putting too much stress on the pipes.
It damages the vessel walls.
And just as importantly, it increases the workload on the left ventricle.
Forcing it to pump against higher resistance.
Right, which leads to hypertrophy or thickening of the heart muscle.
And that just accelerates the whole process of atherosclerosis and heart failure.
And finally, controlling diabetes.
Uncontrolled hyperglycemia is a triple threat.
It promotes dyslipidemia, it makes platelets stickier, and it directly impairs endothelial function.
All of which accelerate CAD.
The book also makes a point to address gender considerations and historical biases in care.
Yes.
We know women tend to have cardiovascular events about 10 years later than men.
But once they do, they have a higher rate of complications and mortality.
Largely due to that belayed recognition from atypical symptoms.
Exactly.
And the textbook provides a really important clarification on hormone therapy or HT.
This used to be so controversial.
It was.
But the evidence is clear now.
HT is not recommended for preventing CAD.
The increased risk of blood clots, stroke, and even an increased incidence of CAD itself outweighs any potential benefit for the heart.
Okay, let's pivot to the clinical presentation itself, angina pictoris.
The pain that happens when oxygen demand outstrips supply.
Right.
And it's because the heart muscle is already incredibly efficient.
At rest, it's already using 70 to 80 % of the oxygen in the coronary blood flow.
So if demand goes up from exercise or stress?
The only way to meet that demand is to increase blood flow.
And if your arteries are narrowed by plaque, the flow can't increase and you get ischemia almost instantly.
The key feature of angina is that the pain is reversible, right?
That's what separates it from an MI.
It is.
The pain goes away with rest or nitroglycerin.
And the source material breaks angina down into four distinct types.
Let's go through them based on CHIRT 23 -2.
First is stable angina.
This is predictable.
It happens at a consistent level of exertion, lasts a few minutes, and is reliably relieved by rest or NTG.
So it's manageable.
The real emergency is unstable angina.
That's the red flag.
It's new pain, or existing pain that's getting much worse, more frequent, or lasts longer.
And critically, it can happen at rest and is not relieved by rest or nitro.
That is ACS.
And the other two types?
Variant angina, or Prince metals, is pain at rest caused by a coronary artery vasospasm.
And then there's silent ischemia, which we already touched on.
Objective evidence of ischemia with no symptoms.
And for older adults, we have to remember they might not present with pain at all.
Right.
They might just show up with dyspnea, weakness, or even confusion.
So medical management of angina.
The goal is to decrease demand and increase supply.
Nitrates are the first line.
Nitroglycerin is a potent, fast -acting vasodilator.
It primarily works on the veins, which causes blood to pool in the periphery.
Reducing preload, the amount of blood returning to the heart.
Exactly.
Which dramatically decreases the heart's workload.
It also relaxes arteries to a lesser extent, which reduces afterload.
The patient teaching for sublingual NTG is life -saving.
Let's walk through chart 23 to 3.
The instructions have to be crystal clear.
The tablet goes under a moist tongue.
Don't swallow your saliva until it's dissolved.
And you can take it before an activity that you know causes pain.
Yes, prophylactically.
And crucially, they must sit down when they take it, because it can cause hypotension and make them pass out.
The storage is also really important.
It's volatile.
It has to be in its original dark glass container, away from heat and light.
And they need a new supply every six months to make sure it's potent.
Okay, and what is the absolute protocol for calling 911?
This needs to be drilled into them.
If you have pain, take one tablet.
If the pain is still there after five minutes, take a second.
If it's still there after another five minutes, take a third and call 911 immediately.
So if the pain isn't gone within 15 minutes and after three tablets?
It's an emergency.
Okay, next up, the beta blockers.
Metoperolol, for example.
These work by blocking the sympathetic stimulation to the heart.
So they slow the heart rate, decrease the force of contraction, and lower blood pressure, all of which reduces the heart's oxygen demand.
What are the key nursing warnings for beta blockers?
Never stop them abruptly.
That can cause rebound angina or even an MI.
And they can mask the symptoms of hypoglycemia in patients with diabetes.
And the calcium channel blockers?
CCBs, like diltiasm, also slow the heart rate and decrease contractility.
But a key difference is that they also dilate the coronary arterioles, which actually increases oxygen supply.
They're great for hypertension and vasospasm.
Let's shift to the drugs that prevent clots, starting with the most basic one, aspirin.
Aspirin is fundamental.
It's an antiplatelet agent.
Patients get a loading dose and then a daily maintenance dose, usually for life.
And then there are the other antiplatelets, like clopidogrel.
Right, the ADP receptor antagonists.
These are often used in addition to aspirin, what we call dual antiplatelet therapy, especially after a stent is placed.
The biggest risk, of course, is bleeding.
And what about anticoagulants, like heparin?
Unfractionated IV heparin prevents new clots from forming.
It requires very close monitoring of the APTT.
Low molecular weight heparin, or LMWH, is an alternative that doesn't require that constant lab monitoring.
The nursing imperative here is strict bleeding precautions.
It's non -negotiable.
Applying pressure for 5 to 10 minutes after a needle stick, no IM injections, and watching for signs of HIT heparin -induced thrombocytopenia.
Okay, so when a patient with angina is hospitalized, the nursing process starts with a really detailed pain assessment.
It's like being a detective.
You need the full story.
Chart 23 -4 lays it out.
Location, description, a rating from 0 to 10, duration, what brought it on, what made it better.
And you have to compare it to their usual pain pattern.
That's the most important part.
A change in their pattern, especially if it's no longer relieved by rest or nitro, signals a shift to unstable angina or MI.
So let's walk through the immediate nursing actions when a patient reports chest pain.
This is a critical sequence.
Okay, step 1.
The moment they report pain, you assess it and get a set of vitals.
Step 2.
Intervention.
Administer nitroglycerin sublingually.
And you monitor their response, both their pain level and their blood pressure.
If the pain persists.
Step 3.
Repeat the NTG.
You can give up to three doses, five minutes apart.
You assess after every single dose.
Step 4.
Oxygen.
Right.
Put them on supplemental oxygen, usually two liters by nasal cannula.
And if after all that, after three doses, the pain is still there.
Step 5.
You evaluate for an acute MI.
That means getting a stat 12 lead ECG, notifying the provider immediately, and preparing for definitive intervention.
Beyond the physical, managing anxiety is also a physiological intervention.
It really is.
Anxiety revs up the sympathetic nervous system, which increases heart rate and oxygen demand.
It's working against everything you're trying to do.
So a calm presence, honest information.
And a quiet environment are all part of the treatment.
All right, let's move from reversible ischemia to irreversible damage.
Acute coronary syndrome and myocardial infarction.
What's the final step that turns unstable angina into an MI?
It's usually the rupture of that vulnerable plaque we talked about.
That triggers a rapid complete thrombus that totally blocks the artery.
Blood flow stops and the heart muscle starts to die.
And this is where the mantra time is muscle comes from.
It dictates everything we do.
Infarction happens over minutes to hours.
The longer the delay in restoring blood flow, the more heart muscle dies.
We are literally in a race against the clock.
When you're assessing a patient having an MI, what are those classic signs of sympathetic stimulation from chart 23 to 6?
The body is in crisis mode.
You'll see cool, pale, clammy, sweaty skin.
They're often tachycardic and tachypneic.
And many report this profound sense of anxiety or impending doom.
You might also hear new heart sounds.
Yes, a new murmur or a gallop rhythm like an S3 or S4.
You might see JVD if heart failure is developing, nausea, vomiting, and decreased urine output, which is a very bad sign of low cardiac output.
Diagnosis relies on two key tools.
The first is the ECG, and it has to be done immediately.
Within 10 minutes of arrival or symptom onset, it's the fastest way to figure out what's going on and guide treatment.
Let's visualize the damage on the ECG.
What are the three key changes?
First is ischemia, which shows up as T wave inversion.
Next is injury, and this is the big one.
ST segment elevation.
The STEMI.
Exactly.
The ST segment, which is normally flat, rises up.
This is the sign of acute significant damage.
And then the final irreversible change is necrosis.
And that's the abnormal Q wave.
Right.
A deep wide Q wave develops because that dead tissue is electrically inert.
A new Q wave means permanent damage.
So the ECG, combined with cardiac biomarkers, gives you this specific diagnosis.
Right.
Unstable angina is symptoms, but no ST elevation and normal biomarkers.
A STEMI is symptoms plus ST elevation.
And a STEMI is elevated biomarkers, confirming cell death, but no ST elevation.
Let's talk about those biomarkers.
Traponin is the gold standard.
It is.
It's very specific to cardiac muscle.
It rises within a few hours and stays elevated for up to two weeks.
What about the other markers like CKMB and myoglobin?
CKMB is also cardiac specific, but it peaks and falls faster than Traponin.
Myoglobin rises very quickly, but it's not specific.
It can come from skeletal muscle, too.
Its main use is ruling out an MI.
If it's negative, an MI is unlikely.
Okay.
Initial management.
The textbook in chart 23 -7 outlines M -O -N -A.
Morphine, oxygen, nitroglycerin, aspirin.
Morphine is for pain and anxiety, but it also reduces preload and afterload, which helps decrease the heart's workload.
Now, I remember you mentioned there was some caution around morphine use.
There is.
Some studies suggest it might interfere with the absorption of certain antiplatelet drugs.
However, in the acute setting, relieving severe pain and anxiety is so critical to breaking that sympathetic stress cycle that remains the standard of care.
You just have to monitor very closely for hypotension and respiratory depression.
And then within 24 hours, you start two other key drug classes.
Beta blockers to reduce myocardial oxygen consumption and ACE inhibitors.
ACE inhibitors are crucial because they've been proven to decrease mortality and prevent adverse ventricular remodeling.
It's where the damaged ventricle starts to enlarge and change shape, which is a direct path to heart failure.
ACE inhibitors help stop that process.
But the ultimate goal is reperfusion, opening that blocked artery.
The preferred method is emergent PCI.
That's the gold standard for a STEMI.
And the benchmark is the door to balloon time.
Which has to be under 60 minutes from the time the patient hits the door to the time the balloon is inflated in the cath lab.
And if PCI isn't available, then you use thrombolytics or clot busting drugs.
Here, the target is the door to needle time, which must be less than 30 minutes.
Okay.
Once the patient is stable, they enter cardiac rehabilitation.
Let's talk about the three phases.
Phase I starts in the hospital.
It's all about early, gentle mobilization and foundational education on self -care.
Then phase two is outpatient.
Right.
This is usually four to six weeks of supervised ECG -monitored exercise, a few times a week.
It also includes intensive education sessions.
And phase three is long -term.
That's the maintenance phase.
It's self -directed, but focuses on maintaining that cardiovascular conditioning for life.
In the critical care unit, for a patient with ACS,
what are the priority nursing interventions?
Physical rest is key.
We elevate the head of the bed.
This improves breathing, but it also uses gravity to decrease venous return to the heart, which reduces preload and cardiac work.
And we keep coming back to prompt pain relief.
Because it breaks that vicious cycle of pain, fear, and sympathetic stimulation that just taxes the heart even more.
You also have to monitor respiratory function very closely.
Yes, because the damaged heart can easily get overwhelmed, leading to fluid backing up in the lungs.
So you're listening for crackles, monitoring fluid status, and encouraging deep breathing.
And reducing anxiety.
Chart 23 -9 really emphasizes this.
The nurse has to be a calming, trusting presence, provide simple, honest information, and give the patient a chance to talk about their fears.
It's a terrifying experience.
So let's move on to the invasive procedures, starting with PCI.
What's the basic mechanism of PTCA, the balloon angioplasty?
A catheter with a balloon on the tip is guided to the blockage.
The balloon is then inflated for a few seconds.
And that does what?
It physically squishes the plaque against the artery wall and stretches the vessel open, restoring blood flow.
But the artery can just narrow down again.
That's where stents come in.
Exactly.
A stent is a metal mesh tube that's left in place to act as a scaffold, holding the artery open.
And now we mostly use drug eluting stents, or DES.
Right.
They're coated with a medication that slowly leeches out to prevent scar tissue and clots from forming inside the stent.
It dramatically improves long -term results.
But because that stent is a foreign body, the antiplatelet therapy after is absolutely critical.
Is the most important teaching point.
They must take daily aspirin indefinitely, plus another antiplatelet like clopidogrel for at least one full year.
Stopping that therapy early is the biggest cause of stent thrombosis, which is often fatal.
What are the major complications of PCI from table 23 .3?
During the procedure, you worry about dissection of the artery or an MI.
After, the biggest concern is the access site, bleeding hematoma.
And the textbook highlights a really dangerous one, retroperitoneal hematoma.
This is a life -threatening bleed.
It's when the femoral artery puncture leaks blood back into the retroperitoneal space.
The signs are often vague new back or flank pain,
with sudden hypotension and tachycardia.
You have to recognize that immediately.
Post PCI tear is all about managing that access site.
Yes.
After the sheath is pulled, the patient has to lie absolutely flat with the affected leg completely straight for several hours to prevent bleeding.
And sheath removal itself can cause a vasovagal response.
It can.
The pressure can cause the heart rate and blood pressure to drop suddenly.
The nurse needs to be ready with IV atropine.
When PCI isn't an option, we move to open -heart surgery.
See a BG.
What are the key indications?
Usually it's for very extensive multi -vessel disease or complex blockages that aren't good for stenting.
The artery to be bypassed has to be at least 70 % blocked.
And what do they use for the bypass grafts?
The gold standard is the internal thoracic artery, or ITA.
It has an incredible long -term patency rate over 90 % at 20 years.
But you can't use that for everything, so they also harvest veins.
Usually the saphenous vein from the leg.
A key nursing point here is that patients often have significant leg edema after.
And vein grafts just aren't as durable as arterial grafts.
Okay, let's talk about the traditional CIBG procedure.
It involves the cardiopulmonary bypass machine.
Right.
The chest is opened, and the patient is hooked up to the CPB machine, which takes over the function of the heart and lungs.
How do they actually stop the heart to operate on it?
They inject a cold potassium -rich solution called cardioplegia into the coronary arteries.
And to protect the organs, the patient's body temperature is lowered, usually to around 28 degrees Celsius, to slow down metabolism.
So there are alternatives to that, like off -pump CABG.
Or PCB.
The chest is still opened, but the heart keeps beating.
The surgeon uses a stabilization device to hold just the small area of the heart they're working on still.
It's associated with fewer complications like stroke and kidney injury.
Okay, so let's get into the nursing management for cardiac surgery.
Pre -op is all about optimization.
Yes.
The book points out that continuing medications like aspirin, beta blockers, and statins right up until surgery is linked to better outcomes.
And what's the focus of the assessment?
You need a solid baseline of their neurologic and physical status.
And you have to pay close attention to comorbidities.
Poorly controlled diabetes, for instance,
dramatically increases the risk of infection.
Infection prevention is a huge focus.
It is.
Patients will shower with an antiseptic solution, and often use a nasal antibiotic ointment to reduce the risk of surgical site infections from staph or asis.
The pre -op teaching has to be very direct about what they'll experience.
You have to prepare them for the ICU.
And the ventilator, chest tubes, all the lines.
And you have to tell them they won't be able to talk when they wake up because of the breathing tube.
So you teach them how to do their deep breathing and coffee exercises before the surgery.
Once they're in the ICU,
it's continuous multi -system assessment.
Every four hours, at least a full neurocheck.
Continuous cardiac monitoring, HR, rhythm, BP, hemodynamic pressures like CVP and potopy,
respiratory status, chest tube drainage.
And watching renal function is a direct window into cardiac output.
Absolutely.
Urine output less than 0 .5 millikare hour is a huge red flag that cardiac output is dangerously low.
Let's talk through the major potential complications from table 23 to 4, starting with decreased cardiac output.
This can happen for a few reasons.
Hypovolemia from bleeding is one.
Or you could have cardiac tamponade.
That's when blood collects around the heart and compresses it.
Right.
The signs are sudden hypotension, rising and equalizing CVP and potopy, and pulses paradoxes.
If the chest tube drainage suddenly stops but the patient is crashing, that's a surgical emergency.
Fluid and electrolytes are also notoriously unstable.
Very.
You're watching potassium and magnesium very closely because imbalances can trigger lethal arrhythmias.
And another critical intervention is tight glucose control.
Even in non -diabetics?
An IV insulin drip to keep blood glucose under 180 is standard.
Hyperglycemia cripples the immune system and impairs wound healing.
Postoperative delirium is also a massive concern.
Especially in older patients after CPB.
We call it POD.
It could look like confusion, hallucinations, paranoia.
You screen for it with tools like the CAM -ICU.
Management is about correcting any underlying physiological cause and using non -drug interventions like reorientation and promoting sleep.
And finally, discharge.
What are the key teaching points for the family?
You have to reassure them about the temporary cognitive changes.
Memory loss and poor concentration are normal for six to eight weeks after surgery, and it will get better.
And the physical limitations?
They have to be strict.
No lifting more than five to ten pounds.
No driving for several weeks.
And most importantly, they have to understand that CIBD is a fix, not a cure.
They still have coronary artery disease.
Exactly.
They have to commit to the lifestyle changes and medication adherence for life.
And they need to enroll in cardiac rehab.
Wow.
So after this whole deep dive, what are the essential nursing takeaways?
I think it comes down to a few core principles.
You have to master the difference between stable and unstable angina.
You have to act on time as muscle during an ACS event.
And you have to have relentless multi -system surveillance after any procedure watching for bleeding, fluid shifts, and those subtle signs of delirium.
I think what stands out to me is how much of this is predictable.
The greatest protection against CAD isn't the surgeon's skill or some miracle drug.
It's all about the behavioral changes.
It all comes down to the choices made years before a crisis ever hits.
So we'll leave you with this final provocative thought.
Considering all the potent modifiable risk factors we talked about today—tobacco, diet, cholesterol activity—what one commitment can you make right now to fundamentally change your own cardiovascular trajectory?
Thank you for joining us for this essential deep dive into the management of coronary vascular disorders.
We hope you feel thoroughly informed and ready to apply this critical knowledge.
We'll see you next time.
ⓘ This audio and summary are simplified educational interpretations and are not a substitute for the original text.
Using this chapter to study? Last Minute Lecture is free and student-run. If it helped, consider supporting the project.
Support LML ♥Related Chapters
- Coronary Artery Disease & ACSLewis's Medical-Surgical Nursing: Assessment and Management of Clinical Problems
- Antianginal DrugsLippincott Illustrated Reviews: Pharmacology
- Chronic Stable Angina & Myocardial Infarction TherapyPharmacotherapeutics for Advanced Practice: A Practical Approach
- Critical Care of Patients With Acute Coronary SyndromesMedical-Surgical Nursing: Concepts for Interprofessional Collaborative Care
- Antianginal AgentsFocus on Nursing Pharmacology
- Care of Patients With Coronary Artery Disease and Cardiac SurgeryMedical-Surgical Nursing: Concepts and Practice